Article
Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndrome.
Nature communications - 3 Mar 2026
Batignes Maxime, Luka Marine, Jagtap Surabhi, de Cevins Camille, Nemazanyy Ivan, Leib Jacqueline, Fali Tinhinane, Pierga Alexandre, Zarhrate Mohammed, García-Paredes Víctor, Carbone Francesco, Pérot Brieuc P, Neven Bénédicte, Bader-Meunier Brigitte, Quartier Pierre, Hully Marie, Belot Alexandre, Lepelley Alice, Frémond Marie-Louise, Fischer Alain, Ménager Mickaël M
Abstract excerpt
Aicardi-Goutières syndrome (AGS) is a genetic type I interferon (IFN)-mediated disease characterized by neurological involvement with onset in utero or in childhood. Here, we analyze peripheral blood samples from patients bearing AGS-causing mutations in ADAR1, RNASEH2B or SAMHD1 using single-cell transcriptomics and targeted metabolomics. Using machine-learning approaches and differential gene expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
